Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Human-genes-and-gene-expression-products-V

 Process for oligonucleotide synthesis
OF THE PREFERRED EMBODIMENTS The present invention is directed to methods for linking a ...


 Derivatized oligonucleotides having improved uptake and other properties
OF THE INVENTION Antisense therapeutics can be practiced in a variety of organisms ranging from ...


 Process for the synthesis of oligomeric compounds
What is claimed is: 1. A compound having the formula: ##STR38## wherein: X.sub.4 is Z or H; Z is CN,...


 Processes for the synthesis of oligomeric compounds
OF PREFERRED EMBODIMENTS The present invention provides methods for the preparation of oligomeric ...


 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents
OF THE INVENTION Usually, in the method of synthesis of the radiolabelled platinum ...


 Pharmaceutical composition for diabetic neuropathy
What is claimed is: 1. A method for the prophylaxis of diabetic peripheral neuropathy, which ...


 Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance
This invention aids in fulfilling this need in the art by providing an in vitro, single cycle, ...


 Compositions and methods for sensitive detection of HIV infection and monitoring of drug resistance
OF THE INVENTION The present invention relates to new and useful methods including methods for ...


 Continuous process for ethanol production by bacterial fermentation
The accompanying FIGURE will provide a background for the following discussion in which the method ...


 Stable solution of hyaluronate in a balanced salt medium
What is claimed is: 1. A physiological visco-elastic formulation consisting of sodium hyaluronate ...


 Human genes and gene expression products V

Details
Inventors: Williams, Lewis T.; Escobedo, Jaime; Innis, Michael A.; Garcia, Pablo Dominguez; Sudduth-Klinger, Julie; Reinhard, Christoph; Giese, Klaus; Randazzo, Filippo; Kennedy, Giulia C.; Pot, David; Kassam, Altaf; Lamson, George; Drmanac, Radoje; Crkvenjakov, Rad
Assignee: Nuvelo, Inc. (Sunnyvale, CA)
Primary Examiner: Brusca; John S.
Assistant Examiner:
Attorney, Agent or Firm: Fish & Richardson P.C.

This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.

DETAILED DESCRIPTION OF THE INVENTION The invention relates to polynucleotides comprising the disclosed nucleotide sequences, to full length cDNA, mRNA genomic sequences, and genes corresponding to these sequences and degenerate variants thereof, and to polypeptides encoded by the polynucleotides of the invention and polypeptide variants.
The following detailed description describes the polynucleotide compositions encompassed by the invention, methods for obtaining cDNA or genomic DNA encoding a full-length gene product, expression of these polynucleotides and genes, identification of structural motifs of the polynucleotides and genes, identification of the function of a gene product encoded by a gene corresponding to a polynucleotide of the invention, use of the provided polynucleotides as probes and in mapping and in tissue profiling, use of the corresponding polypeptides and other gene products to raise antibodies, and use of the polynucleotides and their encoded gene products for therapeutic and diagnostic purposes.
Polynucleotide Compositions The scope of the invention with respect to polynucleotide compositions includes, but is not necessarily limited to, polynucleotides having a sequence set forth in any one of SEQ ID NOS:1 2707; polynucleotides obtained from the biological materials described herein or other biological sources (particularly human sources) by hybridization under stringent conditions (particularly conditions of high stringency); genes corresponding to the provided polynucleotides; variants of the provided polynucleotides and their corresponding genes, particularly those variants that retain a biological activity of the encoded gene product (e.
g.
, a biological activity ascribed to a gene product corresponding to the provided polynucleotides as a result of the assignment of the gene product to a protein family(ies) and/or identification of a functional domain present in the gene product).
Other nucleic acid compositions contemplated by and within the scope of the present invention will be readily apparent to one of ordinary skill in the art when provided with the disclosure here



Related patents
  Haptotactic peprides
The invention claimed is: 1. An isolated haptotactic peptide of 20 amino acids consisting of the amino acid sequence as set forth in SEQ ID NO:1, characterized in that ...
  Hepatitis C virus inhibitors
OF THE INVENTION Stereochemical definitions and conventions used herein generally follow McGraw-Hill Dictionary of Chemical Terms, S. P. Parker, Ed., McGraw-Hill Book C...
  Expression of recombinant glyoprotein B from herpes simplex virus
The nucleotide sequence and the amino acid sequence derived therefrom are provided for Herpes Simplex Virus ("HSV") glycoprotein B ("gB") for use in expression of the ...
  Enhancing agent for nerve growth factor production comprising a compound having a coumarin backbone or a compound having a 2-dimethyl chroman backbone
The invention claimed is: 1. A therapeutic agent or prophylactic agent for a disease requiring enhancement of nerve growth factor production, wherein the therapeutic ...
  In vitro packaging of adeno-associated virus DNA
It is an object of the present invention to provide a method for packaging a DNA substrate in an in vitro reaction to produce adeno-associated virus (AAV) particles ...
  Recombinant viral vector system
The present invention relates to the in vitro synthesis of a novel 165 basepair fragment of DNA which contains AAV ITR sequences and which can be synthesized in vitro ...
  Modified adeno-associated virus vector capable of expression from a novel promoter
This invention provides an adeno-associated viral vector comprising the inverted terminal repeat sequences of adeno-associated virus and a nucleic acid, wherein the ...
  Culturable mitochondrial cells with no nucleus, showing mitochondrial activity
OF THE INVENTION Hereinafter, the present invention will be described in detail. (1) Method of Producing the Cells of the Present Invention The present invention ...
  Antisense oligonucleotides inhibiting human bcl-2 gene expression
The invention provides oligodeoxynucleotides and methods for inhibiting growth of lymphoma or leukemia cells, that are types of lymphocytes. An antisense ...
  Process for the synthesis of oligomeric compounds
What is claimed is: 1. A method for the preparation of an oligomeric compound having a moiety of Formula I: ##STR38## wherein: X.sub.4 is Z or H; Z is CN, halogen, ...

0.034

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved